Skip to main content
Signal8

Higgins Michael J

SEC insider (Form 3/4/5 filer). CIK 0001478521. Director at Voyager Therapeutics, Inc. (VYGR) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in LEXINGTON, MA.

Companies Higgins Michael J has filed insider reports for

  • Voyager Therapeutics, Inc. (VYGR): Director
  • Camp4 Therapeutics Corp (CAMP): Director
  • Cyclerion Therapeutics, Inc. (CYCN): Director
Higgins Michael J profile photo

Higgins Michael J

CIK: 0001478521

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Voyager Therapeutics, Inc. logo
VYGR

Voyager Therapeutics, Inc.

Director
Camp4 Therapeutics Corp logo
CAMP

Camp4 Therapeutics Corp

Director
Cyclerion Therapeutics, Inc. logo
CYCN

Cyclerion Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Jun 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    30K shares-
  • Camp4 Therapeutics Corp logo
    CAMP

    Camp4 Therapeutics Corp

    Jun 25, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    9K shares-
  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Jun 3, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    24K shares-
  • Cyclerion Therapeutics, Inc. logo
    CYCN

    Cyclerion Therapeutics, Inc.

    Mar 25, 2025
    Award
    Direct
    9.1K shares at avg. $2.75$25K

1-4 of 4